All Stories

  1. Limited recovery from post-acute sequelae of SARS-CoV-2 (PASC) at eight months in a prospective cohort

    Article • ERJ Open Research, October 2021, European Respiratory Society (ERS)

    Dr David Ross Darley

  2. SARS-CoV-2 neutralizing antibodies: Longevity, breadth, and evasion by emerging viral variants

    Article • PLoS Medicine, July 2021, PLOS

    Professor Stefan Pöhlmann, Dr David Ross Darley

  3. Diffusing capacity of the lung for carbon monoxide: association with long-term outcomes after lung transplantation in a 20-year longitudinal study

    Article • European Respiratory Journal, June 2021, European Respiratory Society (ERS)

    Chung-Wai Chow, Dr David Ross Darley

  4. Immunological dysfunction persists for 8 months following initial mild-moderate SARS-CoV-2 infection

    Article • June 2021, Cold Spring Harbor Laboratory Press

    Dr David Ross Darley

  5. Identifying the association between tacrolimus exposure and toxicity in heart and lung transplant recipients: A systematic review

    Article • Transplantation Reviews, April 2021, Elsevier

    Dr David Ross Darley

  6. Limited recovery from post-acute sequelae of SARS-CoV-2 (PASC) at eight months in a prospective cohort

    Article • March 2021, Cold Spring Harbor Laboratory Press

    Dr David Ross Darley

  7. Persistent symptoms up to four months after community and hospital‐managed SARS‐CoV‐2 infection

    Article • The Medical Journal of Australia, March 2021, Australasian Medical Publishing Co. Pty Ltd. (AMPCo)

    Dr David Ross Darley

  8. Eosinophils in transbronchial biopsies: a predictor of chronic lung allograft dysfunction and reduced survival after lung transplantation — a retrospective single‐center cohort study

    Article • Transplant International, November 2020, Frontiers

    Dr David Ross Darley

  9. Autoantibodies against type I IFNs in patients with life-threatening COVID-19

    Article • Science, September 2020, American Association for the Advancement of Science

    Samya Chakravorty, Dr David Ross Darley

  10. Inborn errors of type I IFN immunity in patients with life-threatening COVID-19

    Article • Science, September 2020, American Association for the Advancement of Science

    Samya Chakravorty, Dr David Ross Darley

  11. COPD treatment choices based on blood eosinophils: are we there yet?

    Article • Breathe, December 2019, European Respiratory Society (ERS)

    Dr. gang wang, Dr David Ross Darley

  12. Tacrolimus exposure early after lung transplantation and exploratory associations with acute cellular rejection

    Article • European Journal of Clinical Pharmacology, March 2019, Springer Science + Business Media

    Dr David Ross Darley

  13. Chest pain and recurrent chylothorax: an unusual presentation of malignant pleural mesothelioma

    Article • Respirology Case Reports, June 2017, Wiley

    Dr David Ross Darley

  14. Donor-derived tuberculosis (TB): isoniazid-resistant TB transmitted from a lung transplant donor with inadequately treated latent infection

    Article • Transplant Infectious Disease, September 2016, Wiley

    Dr David Ross Darley

  15. A rare case of everolimus-induced pulmonary alveolar proteinosis

    Article • The Journal of Heart and Lung Transplantation, January 2016, Elsevier

    Dr David Ross Darley

  16. Laryngeal aspergilloma: a complication of inhaled fluticasone therapy for asthma

    Article • Respirology Case Reports, September 2014, Wiley

    Dr David Ross Darley